| [1].Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: Globocan 2008.[J]. Int J Cancer, 2010, 127(12): 2893-917.[2].Ferlay J, Bray F, Pisani P, et al. Globocan 2002.Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. Updated 2004. http://www-dep.iarc.fr/ Accessed March 31, 2009.[3].Mayne ST, Morse DE, Winn DM. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention, 3rd ed. New York: Oxford University Press; 2006. pp 674-696.[4]. Johnson N, Franceschi S, Ferlay J, et al. Tumours of the oral cavity and oropharynx-squamous cell carcinoma.In: Barnes L, Eveson JW, Reichart P, Sidransky D,editors. Pathology and genetics of head and neck tumours. Lyon, France: World Health Organization/IARC Press; 2005. pp 168-175.[5].Ferlay, J., I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, and others. 2013. GLOBOCAN 2012 V1.0, Cancer Incidence and Mortality Worldwide: IARC Cancerbase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer.http://globocan.iarc.fr.[6].de Camargo Cancela M, Voti L, Guerra-Yi M, et al. Oral cavity cancer in developed and in developing countries: population-based incidence.[J].Head Neck, 2010, 32: 357-67. [7].National Bureau of Statistics of China.China Statistical Yearbook, 2010. Beijing, China: China Statistics Press; 2010.[8].Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer.[J].Oral Oncol, 2009, 45: 309-16.[9].Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics, 2002.[J].CA Cancer J Clin, 2005, 55(2):74-108.[10].Torre LA, Bray F, Siegel RL,et al.Global cancer statistics, 2012.[J].CA Cancer J Clin, 2015, 65(2):87-108[11].Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014, 64(1): 9-29. [12].Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2):115-32.[13].Sankaranarayanan R, Ramadas K, Amarasinghe H, et al.Oral Cancer: Prevention, Early Detection, and Treatment. Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov. Chapter 5:192-195[14].Tsantoulis PK, Kastrinakis NG, Tourvas AD, et al. Advances in the biology of oral cancer.[J]. Oral Oncol, 2007, 43: 523-534.[15].Jemal A, SiegelR, XuJ, et al. Cancer statistics,2010.[J]. CA Cancer J Clin, 2010, 60(5):277-300.[16].Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009.[J]. CA Cancer J Clin, 2009 ,59(4):225-49.[17].Siegel R, Naishadham D, Jemal A.Cancer statistics.[J]. CA Cancer J Clin,2012,62(1):10-29[18].Tanaka S, Sobue T.Comparison of oral and pharyngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000) .[J]. Jpn J Clin Oncol,2005,35(8):488-491[19].NohataN, HanazawaT, KikkawaN, et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).[J]. Hum Genet, 2011, 56(8):595-601.[20].Ferlay J., I. Soerjomataram, M. Ervik, et al. 2013. GLOBOCAN 2012 V1.0, Cancer Incidence and Mortality Worldwide: IARC Cancerbase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer.http://globocan.iarc.fr. 192[21].Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma.[J]. Eur Arch Otorhinolaryngol,2003,260(9):502-8 [22]. S. Müller, Y. Pan, R. Li, et al. Changing trends in oral squamous cell carcinoma with particular reference to young patients:1971-2006. The Emory University experience.[J]. Head Neck Pathol,2008,2, 60-6[23].A.R. Fakih, R.S. Rao, A.M. Borges, et al. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue.[J]. Am. J. Surg,1989, 158, 309-313 [24]. K. Rusthoven, A. Ballonoff, D. Raben, et al. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.[J]. Cancer,2008,112, 345-351[25]. Choi S, Myers JN.Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.[J]. J Dent Res, 2008, 87(1):14-32.[26]. Hashibe M, Brennan P, Chuang SC, et al: Interaction between tobacco and alcohol use and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev, 2009, 18:541-550 [27].Kurihara M, Kirita T, Sasahira T ,et al .Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma.[J]. Br J Cancer, 2013, 108(7):1460-9[28]. National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute Surveillance Research Program, series 9 (1996-2003), 2006[29].Harris L, Sessions R, Hong W. Head and neck cancer: a multidisciplinary approach. Philadelphia: Lippincott-Raven; 1998.[30]. Edge SB BD, Compton CC, Fritz AG, et al:AJCC cancer staging manual (ed 7). New York, NY, Springer, 2010[31]. Williams HK. Molecular pathogenesis of oral squamous carcinoma.[J].Mol Pathol, 2000, 53(4):165-172.[32].J. Ferlay, I. Soerjomataram, R. Dikshit.et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.[J].International Journal of Cancer, 2015, 136( 5): 359-86.[33].Hill BT, Price LA. Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate.[J]. Am J Clin Oncol, 1994, 17 (1):1-5. [34].Brocklehurst PR, Baker SR, Speight PM. Oral cancer screening:what have we learnt and what is there still to achieve.[J].Future Oncol, 2010, 6(2):299-304.[35].Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: Globocan 2008[J]. Int J Cancer, 2010, 127(12): 2893-917.[36].Shah JP, Gil Z. Current concepts in management of oral cancer surgery.[J]. Oral Oncol, 2009, 45(4-5):394-401.[37].Chen W, Zheng R, Zuo T, et al．National cancer incidence and mortality in China, 2012.[J].Chin J Cancer Res, 2016, 28(1):1-11. [38].de Vicente JC, Rodriguez-Santamarta T, Rosado P, et al. Survival after free flap reconstruction in patients with advanced oral squamous cell carcinoma.[J]. J Oral Maxillofac Surg, 2012, 70(2):453-9.[39].Patel SG, Amit M, Yen TC, et al. Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research[J]. Br J Cancer, 2013, 109(8):2087-95.[40].Patel SC, Carpenter WR, Tyree S, et al: Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years.[J]. J Clin Oncol, 2011, 29:1488-94.[41].Chinn SB, Spector ME, Bellile EL, et al: Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma.[J].Otolaryngol Head Neck Surg, 2013,149: 893-899[42].Myers JN, Greenberg JS, Mo V, et al: Extracapsular spread: A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue.[J].Cancer, 92: 3030-3036, 2001[43]. Greenberg JS, Fowler R, Gomez J, et al: Extent of extracapsular spread: A critical prognosticator in oral tongue cancer.[J].Cancer, 97:1464-1470, 2003 |
